BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22768592)

  • 61. Metformin: a biguanide.
    Tanja JJ; Langlass TM
    Diabetes Educ; 1995; 21(6):509-10, 513-4. PubMed ID: 8549253
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Metformin: evidence-based versus rational pharmacotherapy.
    Smits P; Tack CJ
    Neth J Med; 2002 Jul; 60(6):228-30. PubMed ID: 12365465
    [No Abstract]   [Full Text] [Related]  

  • 63. A proof of concept, preliminary study to determine the effect of Yogasnas in controlling type 2 diabetes mellitus in newly detected subjects (when compared to metformin monotherapy).
    Viswanathan V; Chacko PT; Lavanya M; Tilak P
    J Assoc Physicians India; 2006 Dec; 54():965-6. PubMed ID: 17334022
    [No Abstract]   [Full Text] [Related]  

  • 64. [Biguanide].
    Tanaka Y
    Nihon Rinsho; 2012 May; 70 Suppl 3():647-51. PubMed ID: 22768592
    [No Abstract]   [Full Text] [Related]  

  • 65. Metformin: fifty-two not out.
    Campbell IW
    J Indian Med Assoc; 2009 Nov; 107(11):779-84. PubMed ID: 20469782
    [No Abstract]   [Full Text] [Related]  

  • 66. Metformin.
    Bailey CJ; Turner RC
    N Engl J Med; 1996 Feb; 334(9):574-9. PubMed ID: 8569826
    [No Abstract]   [Full Text] [Related]  

  • 67. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
    Goo AK; Carson DS; Bjelajac A
    J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Metformin role in the treatment of type 2 diabetes in 2008].
    Spada A; Philippe J
    Rev Med Suisse; 2008 Jun; 4(160):1392-4, 1396-7. PubMed ID: 18630062
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Metformin, a promising oral antihyperglycemic for the treatment of noninsulin-dependent diabetes mellitus.
    Wildasin EM; Skaar DJ; Kirchain WR; Hulse M
    Pharmacotherapy; 1997; 17(1):62-73. PubMed ID: 9017766
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Metformin: intrinsic vasculoprotective properties.
    Wiernsperger NF
    Diabetes Technol Ther; 2000; 2(2):259-72. PubMed ID: 11469268
    [No Abstract]   [Full Text] [Related]  

  • 71. [Therapeutic renaissance. Biguanides in type-2 diabetes: metformin].
    Neye H
    Pharm Unserer Zeit; 2002; 31(3):264-70. PubMed ID: 12071123
    [No Abstract]   [Full Text] [Related]  

  • 72. Metformin--the gold standard in type 2 diabetes: what does the evidence tell us?
    Bosi E
    Diabetes Obes Metab; 2009 May; 11 Suppl 2():3-8. PubMed ID: 19385978
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Insulin sparing and metabolic control with metformin-insulin combination].
    Isnard F
    Journ Annu Diabetol Hotel Dieu; 1997; ():305-25. PubMed ID: 9296986
    [No Abstract]   [Full Text] [Related]  

  • 74. What every dentist should know about metformin, diabetes, and cancer.
    Frykenberg MR; Schneider A; Bashirelahi N
    Gen Dent; 2015; 63(5):70-2. PubMed ID: 26325646
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Improving management of type 2 diabetes mellitus: 2. Biguanides.
    Quillen DM; Samraj G; Kuritzky L
    Hosp Pract (1995); 1999 Oct; 34(11):41-4. PubMed ID: 10887428
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.